Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ader, R.
Right arrow Articles by Cohen, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ader, R.
Right arrow Articles by Cohen, N.

Psychosomatic Medicine, Vol 37, Issue 4 333-340, Copyright © 1975 by American Psychosomatic Society

ORIGINAL ARTICLES

Behaviorally conditioned immunosuppression

R Ader and N Cohen

An illness-induced taste aversion was conditioned in rats by pairing saccharin with cyclophosphamide, an immunosuppressive agent. Three days after conditioning, all animals were injected with sheep erythrocytes. Hemagglutinating antibody titers measured 6 days after antigen administration were high in placebo-treated rats. High titers were also observed in nonconditioned animals and in conditioned animals that were nor subsequently exposed to saccharin. No agglutinating antibody was detected in conditioned animals treated with cyclophosphamide at the time of antigen administration. Conditioned animals exposed to saccharin at the time of or following the injection of antigen were significantly immunosuppressed. An illness-induced taste aversion was also conditioned using LiCl, a nonimmunosuppressive agent. In this instance, however, there was no attenuation of hemagglutinating antibody titers in response to injection with antigen.


This article has been cited by other articles:


Home page
 Integr. Comp. Biol.Home page
J. S. Adelman and L. B. Martin
Vertebrate sickness behaviors: Adaptive and integrated neuroendocrine immune responses
Integr. Comp. Biol., September 1, 2009; 49(3): 202 - 214.
[Abstract] [Full Text] [PDF]

Home page
 Adaptive BehaviorHome page
D. D. Tsankova
Emotional Intervention on an Action Selection Mechanism Based on Artificial Immune Networks for Navigation of Autonomous Agents
Adaptive Behavior, April 1, 2009; 17(2): 135 - 152.
[Abstract] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
A. K. Vallance
Something out of nothing: the placebo effect
Adv. Psychiatr. Treat., July 1, 2006; 12(4): 287 - 296.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
N. W. Kin and V. M. Sanders
It takes nerve to tell T and B cells what to do
J. Leukoc. Biol., June 1, 2006; 79(6): 1093 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. Tometten, S. Blois, A. Kuhlmei, A. Stretz, B. F. Klapp, and P. C. Arck
Nerve Growth Factor Translates Stress Response and Subsequent Murine Abortion via Adhesion Molecule-Dependent Pathways
Biol Reprod, April 1, 2006; 74(4): 674 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. M. J. Peters, B. Handjiski, A. Kuhlmei, E. Hagen, H. Bielas, A. Braun, B. F. Klapp, R. Paus, and P. C. Arck
Neurogenic Inflammation in Stress-Induced Termination of Murine Hair Growth Is Promoted by Nerve Growth Factor
Am. J. Pathol., July 1, 2004; 165(1): 259 - 271.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. C. Holland
Psychological Care of Patients: Psycho-Oncology's Contribution
J. Clin. Oncol., December 1, 2003; 21(90230): 253s - 265.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. U. GOEBEL, A. E. TREBST, J. STEINER, Y. F. XIE, M. S. EXTON, S. FREDE, A. E. CANBAY, M. C. MICHEL, U. HEEMANN, and M. SCHEDLOWSKI
Behavioral conditioning of immunosuppression is possible in humans
FASEB J, December 1, 2002; 16(14): 1869 - 1873.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
J. C. Holland
History of Psycho-Oncology: Overcoming Attitudinal and Conceptual Barriers
Psychosom Med, March 1, 2002; 64(2): 206 - 221.
[Abstract] [Full Text]

Home page
 Psychosom. Med.Home page
J. K. Kiecolt-Glaser, L. McGuire, T. F. Robles, and R. Glaser
Psychoneuroimmunology and Psychosomatic Medicine: Back to the Future
Psychosom Med, January 1, 2002; 64(1): 15 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. P. Kohm and V. M. Sanders
Norepinephrine and beta 2-Adrenergic Receptor Stimulation Regulate CD4+ T and B Lymphocyte Function in Vitro and in Vivo
Pharmacol. Rev., December 1, 2001; 53(4): 487 - 525.
[Abstract] [Full Text] [PDF]

Home page
 Current Directions in Psychological ScienceHome page
R. Ader
Psychoneuroimmunology
Current Directions in Psychological Science, June 1, 2001; 10(3): 94 - 98.
[Abstract] [PDF]

Home page
 Theory PsychologyHome page
S. D. Brown
Psychology and the Art of Living
Theory Psychology, April 1, 2001; 11(2): 171 - 192.
[Abstract] [PDF]

Home page
 Psychosom. Med.Home page
H. Weiner
Praise Be to Psychosomatic Medicine
Psychosom Med, May 1, 1999; 61(3): 259 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Science CommunicationHome page
T. J. KIRESUK
The Placebo Effect: Public Policy and Knowledge Tranfer
Science Communication, June 1, 1988; 9(4): 435 - 475.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
G. R. Smith Jr, J. M. McKenzie, D. J. Marmer, and R. W. Steele
Psychologic Modulation of the Human Immune Response to Varicella Zoster
Arch Intern Med, November 1, 1985; 145(11): 2110 - 2112.
[Abstract] [PDF]

Home page
 ScienceHome page
R Ader and N Cohen
Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus
Science, March 19, 1982; 215(4539): 1534 - 1536.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
H. LEIGH and M. F. REISER
Major Trends in Psychosomatic Medicine: The Psychiatrist's Evolving Role in Medicine
Ann Intern Med, August 1, 1977; 87(2): 233 - 239.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American Psychosomatic Society